The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson’s and Alzheimer’s Disease Progression
Abstract The first objective is to highlight the lack of tools to measure whether a given intervention affords neuroprotection in…